KLRS
Financials
- Market Capitalization 95.93 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3942 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 5.69 USD | +12.23% | +23.16% | +8.59% | -5.48% | 97.75 M USD | ||
| 3946 |  CGTX Cognition Therapeutics, Inc. - Common Stock | 1.02 USD | -3.77% | +3.03% | +13.33% | -56.41% | 97.00 M USD | ||
| 3971 |  FBIO Fortress Biotech, Inc. - Common Stock | 2.77 USD | -1.07% | -2.12% | -17.56% | +1.84% | 92.38 M USD | ||
| 3972 |  ATRA Atara Biotherapeutics, Inc. - Common Stock | 9.20 USD | -0.54% | -3.87% | +12.47% | -37.63% | 92.35 M USD |
Frequently asked questions about Kalaris Therapeutics, Inc. Common Stock
What is the Kalaris Therapeutics, Inc. Common Stock stock price today?
The current price of Kalaris Therapeutics, Inc. Common Stock (KLRS) is 4.03. Over the past 24 hours, the stock has changed by -1.71%. Follow the KLRS chart for real-time price dynamics.
What is the stock ticker of Kalaris Therapeutics, Inc. Common Stock?
Kalaris Therapeutics, Inc. Common Stock trades under the ticker KLRS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kalaris Therapeutics, Inc. Common Stock stock going up?
KLRS has changed by -2.42% over the last week, +33.00% over the last month, and -60.61% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Kalaris Therapeutics, Inc. Common Stock?
Kalaris Therapeutics, Inc. Common Stock currently has a market capitalization of 95.93 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Kalaris Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Kalaris Therapeutics, Inc. Common Stock reported earnings of -0.48 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Kalaris Therapeutics, Inc. Common Stock net income for the last quarter?
Kalaris Therapeutics, Inc. Common Stock reported net income of -11.52 M for the last quarter. The previous quarter showed -10.86 M, which means net income changed by -6.07%.
How many employees does Kalaris Therapeutics, Inc. Common Stock have?
As of the latest available data, Kalaris Therapeutics, Inc. Common Stock has 20 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Kalaris Therapeutics, Inc. Common Stock stock?
You can buy Kalaris Therapeutics, Inc. Common Stock (KLRS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kalaris Therapeutics, Inc. Common Stock stock?
Investing in Kalaris Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KLRS chart and related analysis on metatrader.com as part of your research.